Upgrade to SI Premium - Free Trial

Chemed (CHE) PT Raised to $436 at RBC Capital

April 27, 2026 4:07 AM
RBC Capital analyst Ben Hendrix raised the price target on Chemed (NYSE: CHE) to $436.00 (from $422.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change